( April 17, 2026, 11:35 AM EDT) -- WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on April 16 reversed a Massachusetts federal judge’s grant of judgment as a matter of law (JMOL) of invalidity on patents held by Teva Pharmaceuticals International GmbH and its American affiliate for lack of written description and enablement; the panel found that a reasonable jury could have found that the invention involved a well-known class of antibodies, rather than a novel genus....